Search
for
Sort by
Research 361–390 of 1000+
- The impact of VDR expression and regulation in vivo
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Association of epidemiological and biochemical factors with premature graying of hair: A case–control study
- Flightless I exacerbation of inflammatory responses contributes to increased colonic damage in a mouse model of dextran sulphate sodium-induced ulcerative colitis
- Role of Polyphenols in Dermatological Diseases: Exploring Pharmacotherapeutic Mechanisms and Clinical Implications
- The investigation of minoxidil-induced [Ca<sup>2+</sup>]<sub>i</sub>rises and non-Ca<sup>2+</sup>-triggered cell death in PC3 human prostate cancer cells
- Pan-tissue scaling of stiffness versus fibrillar collagen reflects contractility-driven strain that inhibits fibril degradation
- The value of immunohistochemical expression of SOX9 and CD34 in alopecia areata
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation
- Pharmacologically altered Androgens, Brain Activation and Response Inhibition in a Stop-Signal Task in Male Heavy Drinkers
- Androgen Receptor Blockade Induces the Phagocytosis of MRSA and Pseudomonas aeruginosa by Monocyte-Derived Macrophages In Vitro
- Platelet-Rich Plasma Contains High Concentrations of DKK1, A Potent Inhibitor of Wnt Signaling that Limits Bone Regeneration and Hair Growth
- Diabetogenic potential of dexamethasone and effect Annona muricata methanolic bark extract as post-exposure therapy in albino rats
- 875 Exploring the role of microRNAs in alopecia areata
- Андрогенетическая алопеция: патогенетические механизмы и подходы к лечению
- Long-term reduction of C-reactive protein by LDL apheresis
- 1343 Efficacy of asymmetric siRNA targeting androgen receptor for the treatment of androgenetic alopecia
- The global regulatory logic of organ regeneration: circuitry lessons from skin and its appendages
- Granzyme B in Autoimmune Skin Disease
- Intermittent treatment with farnesyltransferase inhibitor and sulforaphane improves cellular homeostasis in Hutchinson-Gilford progeria fibroblasts
- Frontal Fibrosing Alopecia: To Treat or Not to Treat?
- An important role of cutaneous lymphatic vessels in coordinating and promoting anagen hair follicle growth
- Managing Cutaneous Manifestations of Hyperandrogenic Disorders
- Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes
- Treatment of Severe Alopecia Areata: Combination Therapy Using Systemic Cyclosporine A with Low Dose Corticosteroids
- Induction of ferroptosis by natural products in non-small cell lung cancer: a comprehensive systematic review